Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Bored. Waiting. Here is some playing with data to look at.

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Sep 19, 2023 7:40pm

249 Views

Post# 35644423

RE:RE:Bored. Waiting. Here is some playing with data to look at.

Nice chart dawg. For the NR and IR patients, perhaps they can optimize drug uptake by the cancer cells in some way? Starve then of iron before treatment in order to increase Ruvidar uptake. Or add transferin to the mix? Or maybe eventually combine Rutherin IV and Ruvidar instillation? For sure there is some cancer cell destruction going on in these NR patients as well so maybe just not 100% or they could use an immune stimulating agent? All imo

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages